For example, similarly to the publicly available breast cancer dataset, we observed a decrease in HLA-E expression in the proprietary ER + /HER2- breast tumors compared to the normal adjacent to tumor tissue, and an increased infiltration of NK cells in four out of five patients (Fig. 4). This evidence concerns the gene ESR1 and breast carcinoma.